bpc 157 pea Healthgevity BPC-157 + KPV + P – TrustScore® 8.3/10 Healthgevity BPC + PEA 500

Call (281) 882-3433 or fill out our contact form to get started

Bioactive Aminos for Regeneration & Repair

Based on these data, the FDA approved tesamorelin (marketed as EGRIFTA) for the reduction of excess abdominal fat in HIVassociated lipodystrophy, not as a general weightloss drug for the wider population. Tesamorelin Risks and Considerations Like all hormonemodulating therapies, tesamorelin carries potential risks, including fluid retention, joint pain, injectionsite reactions, and effects on glucose metabolism in susceptible patients

This blend also includes Vitamin B12, which plays an important role in nervous system health, cellular energy production, and overall vitality